Menu

Blog

Archive for the ‘life extension’ category: Page 169

Jan 14, 2022

Dr Tohru Minamino, MD, PhD — Cardiovascular Aging & Targeted Senolytic Bio-Therapies — Juntendo Univ

Posted by in categories: biotech/medical, life extension

Cardiovascular Aging & Targeted Senolytic Bio-Therapies — Prof. Dr. Tohru Minamino, MD, PhD, Juntendo University, Japan


Dr. Tohru Minamino is Professor and Chairman of the Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine (https://juntendo-cvbm.com/en/about.html). He also serves as Director of the Cardiovascular Medicine, Juntendo University Hospital. He received his MD from the Chiba University Graduate School of Medicine in 1989 and his PhD from Faculty of Medicine, the University of Tokyo in 1997.

Continue reading “Dr Tohru Minamino, MD, PhD — Cardiovascular Aging & Targeted Senolytic Bio-Therapies — Juntendo Univ” »

Jan 13, 2022

Roll up, roll up… it’s the Longevity Biotech Virtual Job Fair!

Posted by in categories: biotech/medical, life extension

Amplifying the longevity biotech space with exciting opportunities and brand-new starts. It’s all about connections!

Jan 13, 2022

Age Expert Answers Aging Questions From Twitter | Tech Support

Posted by in categories: biotech/medical, internet, life extension, robotics/AI

I’ve posted some vids of her before. But here she says at 3:52 that she thinks stopping the aging process is farfetched.


Dr. Morgan Levine, a professor who specializes in the biology of aging, answers the internet’s burning questions about aging. Is there anyway to stop aging? Is aging a disease? Do you age slower in space? Dr. Levine answers all these questions and much more!

Continue reading “Age Expert Answers Aging Questions From Twitter | Tech Support” »

Jan 13, 2022

5 Epinutrients To Slow Down Aging, From A Naturopathic Doctor

Posted by in categories: biotech/medical, life extension

What are epinutrients, you ask? Allow us to explain.


In a 2021 study, naturopathic doctor and functional medicine expert Kara Fitzgerald, N.D., author of Younger You, was able to improve participants’ biological age by three years. Sounds like a tall order, but the intervention was actually pretty simple: With a very doable diet and exercise plan, it only took eight weeks to see these results. “A big reason we actually made a difference in eight weeks’ time is because we very intentionally bathed the body in a high amount of epinutrients,” she says on this episode of the mindbodygreen podcast.

Continue reading “5 Epinutrients To Slow Down Aging, From A Naturopathic Doctor” »

Jan 12, 2022

Mike West on human cellular reprograming and rejuvenation (con S/T en Español)

Posted by in categories: biotech/medical, life extension

Excerpt from an interview made by James Ruhle, founder at Simple Biotech, to Michael (Mike) West, founder and CEO of AgeX Therapeutics.

During this 4 minute excerpt, Mike explains in a nutshell the work he and his team at AgeX are doing “to reverse the aging of cells and tissues in the body in the truest and fullest sense of the work”, and clarifies the reasons why it doesn’t mean to convert and adult into a child.

Continue reading “Mike West on human cellular reprograming and rejuvenation (con S/T en Español)” »

Jan 11, 2022

On Deck Longevity Biotech Presentation: Biological Age Optimization

Posted by in categories: biotech/medical, life extension

Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD

To calculate biological age using Levine’s test, download the Excel file in this link from my website:
https://michaellustgarten.com/2019/09/09/quantifying-biological-age/

Jan 11, 2022

A Robot Caregiver Project Was Awarded a $1.5 Million Grant

Posted by in categories: life extension, robotics/AI

Robots could become crucial caregivers in the near future.

Robots could become crucial caregivers in the future, with new technologies constantly in development to help improve the quality of life for the globe’s aging population and for people with physical disabilities.

Continue reading “A Robot Caregiver Project Was Awarded a $1.5 Million Grant” »

Jan 10, 2022

Dr Anthony Atala, MD — Director, Wake Forest Inst for Regenerative Medicine — Printing Human Tissues

Posted by in categories: bioengineering, bioprinting, biotech/medical, government, life extension

Bio-Printing Complex Human Tissues & Organs — Dr. Anthony Atala, MD — Director, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Wake Forest University.


Dr. Anthony Atala, MD, (https://school.wakehealth.edu/Faculty/A/Anthony-Atala) is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology.

Continue reading “Dr Anthony Atala, MD — Director, Wake Forest Inst for Regenerative Medicine — Printing Human Tissues” »

Jan 10, 2022

Transhumanism (Full Documentary)

Posted by in categories: biotech/medical, bitcoin, cryptocurrencies, cyborgs, education, genetics, life extension, transhumanism

TABLE OF CONTENTS —————
0:00–21:02 : Introduction (Meaning of Life)
21:03–46:14 CHAPTER 1: Transhumanism and Life Extension.

TWITTER
https://twitter.com/Transhumanian.

Continue reading “Transhumanism (Full Documentary)” »

Jan 10, 2022

Genflow to become Europe’s first longevity biotech IPO

Posted by in categories: biotech/medical, business, genetics, life extension

The company is developing novel therapeutics targeting aging in humans and dogs by using genetically modified adeno-associated virus (AAV) vectors to deliver copies of the SIRT6 gene variant found in centenarians. SIRT6 has already been shown to have significant capabilities to repair DNA damage, and Genflow’s aim is to show that it can also improve healthspan and, potentially, increase lifespan. “Our business model is to develop our lead compound, GF-1002, that has already yielded encouraging pre-clinical results,” Leire told us. “We are currently undertaking pre-clinical trials which are expected to take approximately two years.


SIRT6 targeting longevity biotech announces intention to float on the London Stock Exchange, with IPO later this month.